Cannabis Archives

Amfil Technologies Inc (OTCMKTS:AMFE) Shares To Keep Gaining Ground

Amfil Technologies Inc (OTCMKTS:AMFE) shares advanced 11.83% on Tuesday to $0.0189 and were unchanged in after-hours trading. Share prices have been trading in a 52-week range of $0.00 to $0.03. The company has a market cap of $14.52 million at 791.92 million shares outstanding.

Amfil Technologies Inc is a company that operates through its subsidiary, Interloc-Kings Inc, which offers landscape construction and snow removal services in Canada. It also supplies and installs residential and commercial hardscape construction projects, including interlocking stone driveways, walkways, back patio’s, retaining walls and steps, fences, decks and pools, among others during the summer season. Interloc also provides residential winter services in Markham, including winter maintenance services.

The company also owns the rights to Medium Scale Prospecting Mining Permits to over nine sites totaling approximately 10,300 acres in Guyana for exploration of gold. It holds approximately 50% interest in mPact-GROZONE Antimicrobial Systems with distribution rights across the world. The company’s other subsidiaries include Snakes & Lagers Inc. and Snakes & Lattes Inc., which operate board game themed bars and cafes in downtown Toronto, Ontario, Canada.

In a press release, Amfil Technologies Inc shared that the GROzone product line recently received a positive review from Pennsylvania Certified Organic allowing their clients to use it in organic production. Pennsylvania Certified Organics certification program is accredited by the USDA for compliance with the National Organic Program, even as the USDA currently does not recognize it as a crop that can be organically grown or called certified organic just yet.

Still, being allowed to use this product line for any and all forms of what is currently deemed agricultural production is reassuring as marijuana cultivators that want to follow organic practices essentially follow the National Organic Program guidelines. Alternate certifications are currently being developed for the industry.

Also, achieving this certified status allows producers such as Amfil Technologies Inc to charge a premium for “Clean” or “Organic” products. Aside from that, it helps ensure that the producer or manufacturer will never have product recall or product failure due to any elevated levels of harmful ingredients used throughout the grow process that can make them susceptible to liability from the consumer. After all, some reports have revealed that residual pesticide in marijuana led to product recalls and lawsuits recently.

Originally developed in 2014, GROzone is a triple-function sanitization unit capable of naturally eliminating 99.9% of water and airborne pathogens. A unit can also regulate a given facility’s water supply, oxygenating the water and maintaining a consistent PPM infusion of ozone that prevents the formation of algae, bacteria or mold, eliminating the need for pesticides or carcinogenic products.

DISCLAIMER: There is a substantial risk of loss with any speculative asset, especially small cap stocks. The opinions expressed are those of the author, and do not constitute recommendations to buy or sell a stock. Do your own research before committing capital.

Advantis Corporation (OTCMKTS:ADVT) Rolls Out Cannabis Products for Pain Relief

Advantis Corporation (OTCMKTS:ADVT) shares rose 13.56% to $0.0335 and were flat in after-hours trading. Share prices have been trading in a 52-week range of $0.00 to $0.03. The company has a market cap of $13.96 million at 465.48 million shares outstanding.

Advantis Corporation is a company that is focused on helping people take control of their health and pain management needs. It does this through partnerships innovative companies in the nutraceutical and alternative health care industries, making the company uniquely positioned to provide the guidance and support to assist in delivering products and services that address the needs of these individuals. Their strategy involves acquiring ownership in developing companies and providing consultation to improve product lines, expand distribution channels, and heighten brand value. Advantis concentrates on healthcare and pain management sectors that forecast staggering growth, identifying partners that possess the potential to capitalize on this trend.

In a press release yesterday, Advantis Corporation announced that it begins distribution of topical cannabis roll-on and Tinctures to treat pain conditions. In particular, Elixicure is a line of CBD dominant products used to treat pain without the psychoactive effects associated with THC. Its pain relief roll-onis specially formulated, using the extract of the cannabis plant, which contains the principal cannabinoid CBD while the pain cream includes over 90% Certified Organic ingredients and is specially formulated with Counter-Irritants to block pain receptors and Salicylic Acids to provide a deep penetrating Aspirin-like relief.

Elixicure utilizes the purest, pharmaceutically derived essential oils and active ingredients to create products that are superior in quality than those available in the marketplace today, and we are very excited to add them to our rapidly growing portfolio of products,” said Advantis Corporation CEO Christopher Swartz in a recent press conference.

The company has been on an all-out media blitz to provide exposure to deliver attention to their progress and product lines. They have also tapped UFC Legend Kimo Leopoldo as a brand ambassador since many high-profile fighters have been lobbying to make CBD remedies legal.

My passion for fighting has been a painful one. The day-to-day grind in the gym as well as the battles in The Octagon left me with aches and pains. The doctors prescribe medicines that may help with this pain, but the side effects from those medicines outweigh the benefits. The Elixicure line of products have relieved my pain with zero side effects,” said Kimo.

In a previous announcement CEO Swartz hinted that “revenue is about to explode” as the company has several efforts lined up for 2017. He added that the company is poised to reach its highest revenue ever for the year and that this momentum can be sustained in the foreseeable future.

We have seen the problem with chronic pain conditions increase exponentially and with that, opiate misuse and addiction as well. I have personally seen all this happen and have observed (too many times) people whom have lost hope,” Swartz further explained, “I have been passionate about creating solutions to effectively treat the masses without the negative side effects associated with opioids. Elixcure is the answer, and we are excited beyond belief to share this remedy with everyone in need.”

Don’t Miss This Bullish Run on OWC Pharmaceutical Research Corp (OTCMKTS:OWCP)

OWC Pharmaceutical Research Corp (OTCMKTS:OWCP) shares rose 36.57% on Friday to $0.915 and were flat in after-hours trading. Share prices have been trading in a 52-week range of $0.00 to $0.95. The company has a market cap of $128.82 million at 135.31 million shares outstanding.

OWC Pharmaceutical Research Corp is a medical cannabis research and development company. As such, it is engaged in the research and development of cannabis-based medical products for the treatment of multiple myeloma, psoriasis and fibromyalgia, as well as development of a cannabis soluble tablet delivery system that has applications for other indications.

The company also provides consulting services to governmental and private entities to assist them with developing and implementing various medical cannabis programs. It was engaged in two business activities: work with GUMI to commercialize and market the Company’s Electromagnetic Percussion Device, and research and development of Cannabis-based medical products for the treatment of a range of medical conditions and/or diseases, such as multiple myeloma, psoriasis, post-traumatic stress disorder migraines and a delivery system.

Last week, OWC Pharmaceutical Corp announced that it would be presenting at the Wall Street Conference, which will be held at the Hilton Doubletree Hotel and Conference Center in Deerfield Beach, Boca Raton, Florida, on Wednesday, March 1, 2017. This premiere conference in the venture capital arena and small-cap marketplace includes industry leaders from the hedge fund, investment banking, and private equity worlds, as well as sophisticated investors, who attend to discuss significant trends in the financial markets.

The Wall Street Conference is one of the leading conferences for small-cap investors and OWC is excited to be a part of it. OWC continues to make significant progress in the research and development of cannabis-centric medical treatments, specifically with our psoriasis cream, which is being readied for the U.S. and European markets. We are focused on having our products on the shelves in the MMJ states this year. I am very much looking forward to discussing the Company with conference attendees,” remarked Ziv Turner, OWC Pharmaceutical Corp’s VP Business development and Managing Director of One World Cannabis.

Member of the company’s Advisory Board, Jeffrey Friedland, is a featured speaker at the Conference and is expected to discuss the opportunities for public company investments in the cannabis sector, and the positive impact that Israeli science and companies are having on the U.S. and Canadian cannabis markets. He is also CEO of Intiva Inc., which was an early-stage investor in OWC, and the author of Marijuana: The World‘s Most Misunderstood Plant.

The legal cannabis market has expanded considerably over the past two years, generating significant and growing investor interest. However, there are only a handful of publicly-traded companies focused on cannabinoid-based, pharmaceutical development and a true scientific approach to product development. I intend to discuss what I see as the publicly-traded cannabis opportunities at the Conference,” Friedland noted.

How Canopy Growth Corp (TSE:WEED) Shares Reacted to Earnings

Canopy Growth Corp (TSE:WEED) shares were down 8.08% to $11.95 on Tuesday and flat in after-hours trading. Share prices have been trading in a 52-week range of $2.70 to $17.86. The company has a market cap of $1.99 billion at 159.13 million shares outstanding.

Formerly known as Tweed Marijuana Inc, Canopy Growth Corp is a diversified cannabis company. Through its subsidiaries Tweed Inc. (Tweed), Bedrocan Canada Inc. (Bedrocan) and Tweed Farms Inc. (Tweed Farms), is engaged in the business of producing and selling legal marijuana in the Canadian medical market. It is also focusing on producing and selling marijuana in the recreational market in Canada. Its core brands are Tweed and Bedrocan.

Tweed is a licensed producer of medical marijuana. Tweed’s commercial license covers approximately 168,000 square feet of its Smiths Falls facility and allows Tweed to produce and sell approximately 3,540 kilograms of medical marijuana per year. Tweed’s built-out production capacity is over 10 climate controlled indoor growing rooms. Bedrocan is a medical-grade cannabis. Bedrocan’s over 52,000 square feet production facility in Toronto, Ontario is licensed, and includes over 30 vegetative and growing rooms, and over three dispensing rooms.

Canopy Growth Corp recently printed its quarterly earnings figures and investors seem unimpressed. The company reported over 29,000 registered patients at December 31, 2016 compared to over 8,000 at December 31, 2015, representing a greater than 260% increase. It made revenue of $9.8 million, which amounts to a 15% increase over the second quarter in the fiscal year 2017 and 180% increase over the prior year period.

However, the company admitted that revenue growth was limited by the product mix available for sale, as supply was limited in the quarter due to rigorous procedures to fully test the record harvest and approve the extensive product released for sale subsequent to quarter end. Still, it was able to harvest a record 5,264 kilograms compared to 1,711 kilograms in the second quarter fiscal year 2017, which amounts to a 208% increase.

The third quarter provided new opportunities and challenges for our business, with demand largely exceeding supply throughout the quarter,” said Bruce Linton, Chairman & CEO of Canopy Growth Corp. “A function of our growing patient base, the time required to move from a record harvest to sale, and an extensive phenotyping exercise to establish breeding stock and further elevate our product offering all resulted in constrained product available for sale during the quarter. The successful late-quarter harvest of the Tweed Farms facility running at full capacity has begun to ease supply constraints while at the same time we have introduced a new diversity of product into our online store under the Tweed, Leafs By Snoop and DNA Genetics banners, driving strong sales this month.”

Other developments over the period included the acquisition of a 472,000 square foot and 42 acre property at 1 Hershey Drive, Smiths Falls, Ontario on January 13, 2017. This is on top of the acquisition of Mettrum Health Corp on January 31, 2017 and the change in the TSX trading symbol from CGC to WEED early this month.

We continued to push the boundaries of our business during the quarter through multiple strategic accomplishments that will help drive our future growth. We worked to strengthen our market position in Canada with our move to acquire Mettrum and the acquisition of Vert Cannabis to establish a unique brand presence in Quebec. We also established a base of operations in Germany, a strategic future market for Canopy, with the purchase of cannabis distributor, MedCann GMBH,” added Linton.

One Bullish Prospect After Another for Zerez Holdings Inc (OTCMKTS:ZRZH)

Zerez Holdings Inc (OTCMKTS:ZRZH) shares were up 18.18% on Tuesday to $0.0449 and flat in after-hours trading. Share prices have been trading in a 52-week range of $0.00 to $0.06. The company has a market cap of $211 million at 5.57 billion shares outstanding.

Zerez Holdings Inc is a public equity corporation that is focused on the advanced agriculture and cannabis industries with plans to grow through acquisition, strategic alliances, and proprietary intellectual property. The company’s wholly owned subsidiary Next Generation Farming provides turnkey commercial greenhouse and automation systems that improve yields and decrease water consumption for cultivators of organic food and cannabis crops.

In a press release yesterday, Zerez Holdings Inc reported that its subsidiary Next Generation Farming Inc has signed its Co-Marketing partner Sweet Leaf Hydroponics to a wholesale purchase contract for a minimum of $1 million dollars worth of NextGen’s “SMART by Design” line of advanced and automated greenhouse systems by the end of the year. On top of this, Sweet Leaf has also ordered 2 30ft. x 24ft. production models to be built as walk-thru demonstration facilities at each of their sales locations.

“It was imperative that we enlisted the feedback about our marketing strategy, product designs, configurations, pricing and overall sales and support strategy with Jay and our extended team at Sweet Leaf Hydro. They sell millions in revenue to thousands of clients and we wanted to leave no stone unturned before our upcoming launch. Obviously we have a good plan for Jay to make such a strong minimum sales commitment to us,” said John Taylor and Don Smith of Zerez Holdings Inc.

For Jay DeSalvatore, president of Sweet Leaf Hydroponics, the companies are in full alignment and are confident that they can easily re-sell a million dollars of their products by the end of the year. Sweet Leaf has hundreds of regular customers and lots of immediate greenhouse sales opportunities.

“The data we continue to see is that the smart greenhouse marketplace is worth a minimum of $6 billion in 2017. Although we see most of our sales being on the commercial scale, with multi-faceted customer relationships, we have created some unique and surprising products that will be available for immediate purchase when we launch. We intend to smartly capture our profitable share of this market. If Zerez Holdings and Next Generation Farming earn just 10-20% market share, that translates into potential revenues of $600 Million to $1.2 billion annually. Obviously, we are ramping our business quickly, and we are confident we can handle that level of growth when it comes,” Taylor added.

In January, Zerez Holdings Inc announced that it has sold another “SMART by Design” greenhouse system to its first repeat client, a Northern California Cannabis cultivation company, from earlier in the month.

“When a client comes back and orders from you again that is our definition of consumer confidence. We are very pleased that the trust, confidence and great working relationship with our customer has resulted in a second order in less than 10 days,” Taylor shared.

Why Earth Science Tech Inc (OTCMKTS:ETST) Shares Rose Nearly 30%

Earth Science Tech Inc (OTCMKTS:ETST) shares were up 27.78% to $1.38 on Monday to $1.38 and flat in after-hours trading. Share prices have been trading in a 52-week range of $0.18 to $1.70. The company has a market cap of $55.85 million at 40.47 million shares outstanding.

Earth Science Tech Inc is a biotechnology company that is focused on nutraceuticals and bioceuticals for use in various industries, such as health, wellness, nutritional supplements, cosmetic and alternative medicine to manage illnesses and the quality of life for consumers around the world. It sells its products through its retail store located in Coral Gables, Florida, and through the Internet.

The company is also focused on delivering nutritional and dietary supplements that help with treating symptoms, such as chronic pain, joint pain, inflammation, seizures, high blood pressure, memory loss, depression, weight management, nausea and aging. This may include products, such as vitamins, minerals, herbs, botanicals, personal care products, homeopathies, functional foods and other products. These products will be in various formulations and delivery forms, including capsules, tablets, soft gels, chewables, liquids, creams, sprays, powders and whole herbs.

In a press release this week, Earth Science Tech Inc announced that itsnew wholly owned subsidiary, Cannabis Therapeutics, Inc. will be releasing new Cannabinoid-based Drugs and Nutraceuticals. In particular, Cannabis Therapeutics will begin by inventing & launching 2 new cannabinoid-based pharmaceutical drugs and 3 new advanced cannabinoid-based nutraceutical products using Earth Science Tech’s existing Cannabis CBD Patent, IP, invention, technology and future technology.

“I am very enthusiastic about Cannabis Therapeutics position in the cannabis industry to become a leader in cannabinoid research and development. Our imminent new developments and efforts have the potential to expedite our numerous upcoming cannabis cannabinoid-based therapeutic products to help aid people with certain conditions and disorders worldwide, in the later part of 2017. We are focused on cannabinoid-based therapeutic drugs, functional foods and nutraceuticals (retail consumer markets worldwide). We look to announce later this week a New Scientific Advisory Board which will include myself, Dr. Michel Aube, as the Chairman of the Advisory board to Cannabis Therapeutics, Inc. as well as other World Class Scientists,” said Dr. Michael Aube, CEO of Earth Science Tech Inc.

Cannabis Therapeutics plans on distinguishing itself from many competing cannabinoid-focused biotechnology companies with its competent capital apportionment. Its board of directors and upcoming new scientific advisory board intends to broaden the current operations of the Cannabis Therapeutics to include a variety of other products, solutions, laboratories and expertise. Its goal is to discover solutions for conditions for which there is presently no effective treatment as well as other medical disorders with the application of known and novel cannabis cannabinoid-based products.

ETST is extremely fortunate to have attracted world leaders to our executive leadership team and Board of Advisors. All of them are contributing their passion, time and expertise to the development of Cannabis Therapeutics unique cannabinoid-based products and solutions. Cannabis Therapeutics goal is to help advance the cannabis-cannabinoid healthcare industry and have a positive impact on the wellbeing of humans worldwide” Dr. Aube continued.

Wrapmail Inc (OTCMKTS:WRAP) Sets Foot in Cannabis Industry

Wrapmail Inc (OTCMKTS:WRAP) shares were up 20.30% to $0.0800 and flat in after-hours trading. Share prices have been trading in a 52-week range of $0.01 to $0.15. The company has a market cap of $15.54 million at 146.01 million shares outstanding.

Wrapmail Inc is a company that provides document, project, marketing and sales management systems to business clients through its website and software. It offers WRAPmail, which is a method, system and software for extracting content for integration with electronic mail. WRAPmail is an e-mail templating system that adds graphics and letterhead to everyday e-mails. WRAPmail allows promoting the business.

To top it off, the company offers various solutions, which include WRAPmail Business, WRAPmail Personal and WRAPmail Enterprise. Its business edition solution is offered to any size organization and its personal edition solution is offered to any individual and community group. Its enterprise solution is offered for organizations wanting to host their own environment. It also provides all system integration support for an installation and features click notification alerts and analytical report.

In a press release last week, Wrapmail Inc announced that it acquired 100% of HealthMax Group, which is led by a team of high level scientists and business entrepreneurs and is at the forefront of the CBD market, offering product in its purest form using its proprietary Nano Technology. Its technology was designed to increase product efficacy significantly over just CBD alone, with products that are lab tested to be 99% pure and consistently rated among consumers as their favorite.

After getting to know David and the HealthMax team over the past month, we concluded this acquisition was a great opportunity for HealthMax to enter the public markets, and an incredible value proposition for our shareholders. Utilizing our collective resources, it’s with great enthusiasm we enter into this transaction,” said Wrapmail Inc CEO Marco Alfonsi.

Wrapmail Inc will begin the process to formalize a name and symbol change consistent with the new company profile. WRAPmail and Prosperity Systems will operate as wholly owned subsidiaries. HealthMax will continue to sell classic and nano-technology infused CBD products and is expanding its sales and distributions channels.

I am very proud of the progress we’ve made in the hemp industry over this short time span, as well as our advancements in nano-technology delivery of our imported all-natural hemp. HALO CBD is medicinal grade CBD, which is clear and does not have the harsh hemp taste, black color, residual solvents or toxic fillers like many competing products. Some analysts are projecting a 2-billion-dollar market for the hemp industry, and I think we are poised to be a leading competitor in this market with the addition of our multi-spectrum and nano-technology infused formulations,” said HealthMax Group President and COO David Posel.

He went on to say that HealthMax is expanding to large-scale production and engaging the food and beverage industry. The company plans to disrupt the market and set the bar for higher quality standards across the board.

North American Cannabis Holdings Inc (OTCMKTS:USMJ) Gearing Up for More Gains

North American Cannabis Holdings Inc (OTCMKTS:USMJ) shares were flat on Tuesday at $0.00060 and unchanged in after-hours trading. The company has a market cap of $22,100 at 36.88 million shares outstanding. Share prices have been trading in a 52-week range of $0.00 to $0.00.

North American Cannabis Holdings Inc has entered into the marijuana industry in 2013 to pilot various cannabis sector enterprises and now it is well-positioned to take advantage of the expected boom. The market is expected to grow to $20 billion by 2020 thanks to the November 8 vote that legalized the use of medical or recreational marijuana in several US states. Legislation is pending in Canada as well.

Last year, the company announced that it is set to close the acquisition of controlling interest in Alternet Systems by December 20, 2016. Alternet Systems is a company that develops and commercializes a growing portfolio of digital commerce technologies and already has a long-term track record in financial services industry software solutions.

Along with this announcement, North American Cannabis Holdings Inc also shared that it has partnered with Puration under their EVERx Sports and Fitness Nutritional Supplement Brand Name. These products will be targeted to athletes looking to enhance their performance, as CBD can substantially reduce recovery times and increase cardio output. Apart from that, CBD infused products can also target the general public that is becoming more aware of the health benefits of these products, such as mitigating diabetes risk and reducing cancer cells.

This partnership is ready to bear fruit as Puration and North Cannabis Holdings Inc will reveal the major industry trade show where EVERx Cannabinoil (CBD) Infused Bottled Water will be officially launched.

The launch event is going to be huge, and both USMJ and PURA have big roles to play” said Steven Rash, CEO of North American Cannabis Holdings Inc. “An amazing ensemble of smart people and terrific organizations are coming together for what will be a tremendous launch event. When we tell you all about the EVERx launch event it will be crystal clear to you how USMJ and PURA fit together and how all the hard work getting to this launch has been worth it. EVERx is a winner and you will see it endorsed by winners at our launch event. You don’t want to miss our announcement next week on Thursday, February 2^nd and you don’t want to miss our launch event in March. Put it on your calendar now.”

Earlier this year, Puration published a $3 million revenue plan and later on announced that sales channels are poised to surpass this target. The company’s proprietary extraction process is combined with Alkame Holdings’ patented technology that alters the structure of water, producing a combination of characteristics that are unprecedented in the beverage industry.

I first want to start by saying that Alkame Holdings’ was absolutely the right partner for PURA to pick for producing the EVERx CBD Infused Sports Drink with PURA’s proprietary CBD extract.” said Brian Shibley, CEO of Puration. “ALKM has been great. Not only is ALKM’s patented water a perfect platform for PURA’s proprietary CBD extract, the people at ALKM are simply the best kind of people to work with. They are committed to the mission; passionate about the mission and laser beam focused on the mission. EVERx CBD Infused Water is the best CBD infused water you can find. All of us at PURA, USMJ and ALKM can’t wait to tell you about the product launch details. Just wait until you hear about the product launch plans on Thursday, next week. You’re going to be excited too.”

Tag: Cannabis